M.C. Berchier

633 citations

26 papers · 479 indexed · h-index 14

Oncology top 10%
- Lung Cancer Research Studies 17
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 20
- Lung Cancer Diagnosis and Treatment 8
Epidemiology
- Neuroendocrine Tumor Research Advances 6
Molecular Biology
- Cancer therapeutics and mechanisms 4
Pathology and Forensic Medicine
- Chemotherapy-induced organ toxicity mitigation 2
Hepatology
- Hepatocellular Carcinoma Treatment and Prognosis 2
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 1

Co-authors: G. Bureau Jean‐Paul Sculier O Van Cutsem V. Giner Jean Klášterský P. Mommen Marianne Paesmans J Thiriaux
Cited by: Oncology Pulmonary and Respiratory Medicine Epidemiology
Journals: Lung Cancer (6 papers)Journal of Clinical Oncology (4 papers)Annals of Oncology (4 papers)
Partner nations: Belgium France Greece

In The Last Decade

M.C. Berchier

26 papers receiving 465 citations

Peers

Countries citing papers authored by M.C. Berchier

Since Specialization

Citations

This map shows the geographic impact of M.C. Berchier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Berchier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Berchier more than expected).

Fields of papers citing papers by M.C. Berchier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Berchier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Berchier. The network helps show where M.C. Berchier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M.C. Berchier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M.C. Berchier Line = papers co-authored together M.C. Berchier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier,J.J. Lafitte,Anna Efremidis,Luiza Bordignon Cypriano,J. Lecomte,M.C. Berchier,Michel Richez,Thierry Berghmans,Arnaud Scherpereel,Anne‐Pascale Meert,George Koumakis,Nathalie Leclercq,Marianne Paesmans,P. Van Houtte	2008	21
2	Chemotherapy improves low performance status lung cancer patients European Respiratory Journal ·Jean‐Paul Sculier,J.J. Lafitte,Marianne Paesmans,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Margulis La,Arnaud Scherpereel,Vincent Ninane,George Koumakis,Michael Vaslamatzis,Alina Vladimirovna Musiichuk,T. Berghmans	2007	20
3	European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease Хумойиддин Сафар ўғли Амиров Бахтияр Хушбакович Аманов,M.C. Berchier,Thierry Berghmans,刘广绪,Benoît Colinet,Letícia Gabriele Zilli,V. Giner,V. M. Undritsov,J.J. Lafitte,Ezequiel Rey,Céline Mascaux,A-P Meert,Renato Menezes-Silva,Michel Richez,Consuelo Carvalho Da Costa,Arnaud Scherpereel,J.P. Sculier,P. Van Houtte,Dayron Ortega	2007	1
4	Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party British Journal of Cancer ·(unknown),T. Berghmans,J.J. Lafitte,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Anne‐Pascale Meert,Arnaud Scherpereel,Vincent Ninane,Nathalie Leclercq,M Paesmans,Jean‐Paul Sculier	2007	10
5	A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier,J.J. Lafitte,J. Lecomte,C.G. Alexopoulos,O Van Cutsem,V. Giner,Anna Efremidis,M.C. Berchier,T. Collon,Anne‐Pascale Meert,Arnaud Scherpereel,Vincent Ninane,M Paesmans,T. Berghmans	2007	18
6	A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma Lung Cancer ·T. Berghmans,J.J. Lafitte,Marianne Paesmans,B. Stach,M.C. Berchier,Wilco C. E. P. Verberk,誠林南山,T. Collon,P. Mommen,J.P. Sculier	2005	22
7	A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics British Journal of Cancer ·(unknown),Sculier Jp,M Paesmans,J. Lecomte,O Van Cutsem,J.J. Lafitte,T. Berghmans,George Koumakis,Luiza Bordignon Cypriano,J Thiriaux,J. Michel,V. Giner,M.C. Berchier,P. Mommen,Vincent Ninane,Jean Klášterský	2001	41
8	Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy Clinical & Translational Oncology ·Jean‐Paul Sculier,Marianne Paesmans,Jean‐Jacques Lafitte,園江落合,J Thiriaux,O Van Cutsem,S. Konishi,G. Bureau,M.C. Berchier,A. Golubсzov,V. Giner,Yangming Zheng,池田真人,Thierry Berghmans,Paul Van Houtte,Vincent Ninane,Jean Klášterský	1999	2
9	A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer European Journal of Cancer ·J.P. Sculier,Marianne Paesmans,J Thiriaux,J. Lecomte,G. Bureau,V. Giner,George Koumakis,J.J. Lafitte,M.C. Berchier,C.G. Alexopoulos,Adwoa Yeboaa Owusu,P. Mommen,Vincent Ninane,Jean Klášterský	1999	20
10	A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy Annals of Oncology ·Jean‐Paul Sculier,Marianne Paesmans,J.J. Lafitte,園江落合,J Thiriaux,O Van Cutsem,S. Konishi,G. Bureau,M.C. Berchier,A. Golubсzov,P. Mommen,Thierry Bosschaerts,Thierry Berghmans,P. Van Houtte,Vincent Ninane	1999	24
11	Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Sculier Jp,Marianne Paesmans,J Thiriaux,J. Lecomte,G. Bureau,V. Giner,Anna Efremidis,J.J. Lafitte,M.C. Berchier,C.G. Alexopoulos,Adwoa Yeboaa Owusu,P. Mommen,Vincent Ninane,Jean Klášterský	1998	24
12	Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy Lung Cancer ·Jean‐Paul Sculier,Marianne Paesmans,Vincent Ninane,V. Giner,G. Bureau,J.J. Lafitte,園江落合,J Thiriaux,O Van Cutsem,S. Konishi,M.C. Berchier,A. Golubсzov,P. Mommen,P. Van Houtte,Jean Klášterský	1998	11
13	[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]. PubMed ·Sculier Jp,M Paesmans,P Libert,G. Bureau,G Dabouis,J Thiriaux,Eric Klein,O Van Cutsem,J Schmerber,V. Giner,M.C. Berchier,P. Mommen,R Sergysels,Annette Feliberty Ruiz	1997	9
14	Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier,M Paesmans,G. Bureau,V. Giner,J. Lecomte,J. Michel,M.C. Berchier,O Van Cutsem,Kanthi Srirengan,Frode Krøll,R Sergysels,P. Mommen,Jean Klášterský	1996	54
15	Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC) Lung Cancer ·Xuechuan He,Jean‐Paul Sculier,Marianne Paesmans,Michel Richez,G. Bureau,G Dabouis,J. Lecomte,J. Michel,O Van Cutsem,J Schmerber,V. Giner,M.C. Berchier,R Sergysels,P. Mommen,Jean Klášterský	1996	24
16	Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: Experience of the European Lung Cancer Working Party Lung Cancer ·Jean‐Paul Sculier,G. Bureau,V. Giner,J Thiriaux,Eric Klein,M.C. Berchier,O Van Cutsem,Kanthi Srirengan,Frode Krøll,P. Mommen	1995	10
17	Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer European Journal of Cancer ·Jean‐Paul Sculier,M Paesmans,P Libert,G. Bureau,G Dabouis,J Thiriaux,Eric Klein,O Van Cutsem,J Schmerber,V. Giner,M.C. Berchier,R Sergysels,P. Mommen,Jean Klášterský	1994	28
18	A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer Lung Cancer ·Jean Klášterský,J.P. Sculier,F. Ries,G Dabouis,P Libert,J Schmerber,J Thiriaux,M.C. Berchier,G. Bureau,O Van Cutsem,Rizkiatul Paidiah,R Sergysels,P. Mommen,M Paesmans	1994	5
19	Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier,Marianne Paesmans,G. Bureau,G Dabouis,P Libert,G. Vandermoten,O Van Cutsem,M.C. Berchier,F. Ries,J. Michel	1993	61
20	Monoclonal Immunoradiometric Assay and Polyclonal Radioimmunoassay Compared for Measuring Neuron-Specific Enolase in Patients with Lung Cancer Clinical Chemistry ·Jean‐Jacques Body,Marianne Paesmans,Sculier Jp,G Dabouis,G. Bureau,P Libert,M.C. Berchier,Roffico Roffico,Jean Klášterský	1992	19

About M.C. Berchier

M.C. Berchier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 26 papers that have together received 479 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Diagnosis and Treatment (8 papers), Neuroendocrine Tumor Research Advances (6 papers), Cancer therapeutics and mechanisms (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Oncology (363 citations), Pulmonary and Respiratory Medicine (281 citations) and Epidemiology (161 citations). M.C. Berchier has collaborated with scholars based in Belgium, France and Greece. Frequent co-authors include G. Bureau, Jean‐Paul Sculier, O Van Cutsem, V. Giner, Jean Klášterský, P. Mommen, Marianne Paesmans, J Thiriaux, G Dabouis and J. Lecomte. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact